NCT06117878 2023-11-07Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue SarcomaBase Therapeutics (Shanghai) Co., Ltd.Phase EARLY_PHASE1 Unknown12 enrolled
NCT04864821 2021-05-06Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorPersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase EARLY_PHASE1 Unknown24 enrolled